• Id : RNR-264566
  • Category : Pharma Healthcare
  • Publish Date : Apr-19
  • Publisher : Research-N-Reports
  • Pages : 123
  • Format : PDF
License Type

Acetylcysteine, also known as N-acetylcysteine (NAC), is a modified amino acid that is used as an antidote for acetaminophen overdose to prevent hepatic injury. Acetylcysteine is a hepatoprotective agent and has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.

Scope of the Report:
Acetylcysteine is an efficient API for COPD and PB treatment. Also, it is added in nutritional supplements for cosmetology. Generally, acetylcysteine is mainly used to produce medicine in India and Europe. While in America, it is mainly used in nutritional supplements.
Raw material of acetylcysteine is mainly L-cysteine, which is distributed all over the world. Also manufacture process of acetylcysteine is mature. So, there are many acetylcysteine suppliers globally. Global major producers included in the report are Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo and Manus Aktteva Biopharma. Market concentration in this industry is high. In 2016, sales of those manufacturers account for 77.18% of global total sales.
Global major consumption regions are distributed in USA, Europe and India. In 2016, Europe consumed about 3908.2 MT acetylcysteine. USA and India separately consumed about 3005.4 MT and 1392.3 MT in 2016. Meanwhile, most acetylcysteine API suppliers also produce downstream medicine directly, especially most Europe and India suppliers.
The worldwide market for Acetylcysteine is expected to grow at a CAGR of roughly 22.3% over the next five years, will reach 1650 million US$ in 2024, from 490 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Acetylcysteine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Zambon
- Moehs
- Pharmazell
- Nippon Rika
- Chengyi Pharma
- Wuhan Grand Hoyo
- Manus Aktteva Biopharma

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Spray
- Tracheal Drip
- Tablet

Market Segment by Applications, can be divided into
- Medicine
- Nutritional Supplements
- Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acetylcysteine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Acetylcysteine, with price, sales, revenue and global market share of Acetylcysteine in 2017 and 2018.
Chapter 3, the Acetylcysteine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acetylcysteine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Acetylcysteine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Acetylcysteine sales channel, distributors, customers, research findings and conclusion, appendix and data source.